Blog & News
The Johns Hopkins Center for Communication Programs (CCP) developed a new online resource - Results 4 Informed Choice - to support HIV and family planning program implementers, government representatives, advocates and journalists interested in the potential increased risk of acquiring HIV for women using progestogen-only contraceptives.
The purpose of the website is to connect people with knowledge and tools to support understanding, communication, and advocacy around this issue as well as the outcomes of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial. The tools, resources, and data presented on the site are intended to help stakeholders plan and execute their response to the ECHO trial and ensure that women have all the information they need to make an informed choice when adopting and using a contraceptive method. The website includes resources such as:
- Country profiles with HIV and family planning data
- Peer-reviewed literature
- Program reports
- Communication tools and materials
- Research presentations
- Timeline of key events
- News and updates
The ECHO trial was launched in 2015 to test the comparative risk of HIV acquisition among women using one of the following three contraceptive methods: DMPA (injectable), LNG Implants (Jadelle) and copper intrauterine devices (IUDs). Results of the ECHO trial are expected to be released in mid-2019. No matter the result, there is a need for high-quality communication and advocacy materials and a coordinated response among stakeholders.
If you have materials or research related to hormonal contraception and the potential risk of HIV acquisition to contribute, please upload them directly on the site.
For more information, contact the website managers at firstname.lastname@example.org.